合計 50 件の最近のインサイダー取引記録が記録されています ALX Oncology Holdings Inc. (ALXO), 内訳は 34 件の買い および 12 件の売り. インサイダー買い総額は $12.65M インサイダー売り総額は $47.43K.
最近活動のある主要インサイダーには Lettmann Jason, Pinto Shelly, Klencke Barbara. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — ALXO
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-19 |
Lettmann Jason |
Chief Executive Officer |
情報に基づく売り |
12,311 |
$2.17 |
$26.71K |
293,609 |
| 2026-03-19 |
Pinto Shelly |
SVP, Finance and CAO |
情報に基づく売り |
903 |
$2.17 |
$1.96K |
86,805 |
| 2026-03-03 |
Klencke Barbara |
Chief Medical Officer |
RSU 付与（制限付株式） |
700,000 |
$2.07 |
$1.45M |
700,000 |
| 2026-02-25 |
Klencke Barbara |
Chief Medical Officer |
不明 |
100,000 |
$1.48 |
$148K |
- |
| 2026-02-18 |
Pinto Shelly |
SVP, Finance and CAO |
情報に基づく売り |
565 |
$2.27 |
$1.28K |
87,708 |
| 2026-02-17 |
Lettmann Jason |
Chief Executive Officer |
RSU 源泉徴収 |
2,201 |
$2.27 |
$5K |
305,920 |
| 2026-02-02 |
Goodman Corey S |
10 Percent Owner |
情報に基づく買い |
3,184,713 |
$1.57 |
$5M |
8,453,038 |
| 2026-01-26 |
Lettmann Jason |
Chief Executive Officer |
RSU 付与（制限付株式） |
912,000 |
$1.48 |
$1.35M |
912,000 |
| 2026-01-26 |
Pinto Shelly |
SVP, Finance and CAO |
RSU 付与（制限付株式） |
192,000 |
$1.48 |
$284.16K |
192,000 |
| 2026-01-26 |
Shantharam Harish |
Chief Financial Officer |
RSU 付与（制限付株式） |
303,000 |
$1.48 |
$448.44K |
303,000 |
| 2026-01-20 |
Goodman Corey S |
10 Percent Owner |
RSU 付与（制限付株式） |
40,400 |
$1.32 |
$53.33K |
40,400 |
| 2026-01-20 |
Garland J. Scott |
Director |
RSU 付与（制限付株式） |
40,400 |
$1.32 |
$53.33K |
40,400 |
| 2026-01-20 |
Takimoto Chris H |
Director |
RSU 付与（制限付株式） |
40,400 |
$1.32 |
$53.33K |
40,400 |
| 2026-01-20 |
Hemrajani Rekha |
Director |
RSU 付与（制限付株式） |
40,400 |
$1.32 |
$53.33K |
40,400 |
| 2026-01-20 |
Sandler Alan B. |
Director |
RSU 付与（制限付株式） |
10,100 |
$1.32 |
$13.33K |
10,100 |
| 2026-01-20 |
Curran Daniel J. |
Director |
RSU 付与（制限付株式） |
16,833 |
$1.32 |
$22.22K |
16,833 |
| 2026-01-06 |
Pinto Shelly |
SVP, Finance and CAO |
情報に基づく売り |
3,925 |
$1.11 |
$4.36K |
88,273 |
| 2025-10-14 |
Lettmann Jason |
Chief Executive Officer |
RSU 付与（制限付株式） |
597,500 |
$1.70 |
$1.02M |
597,500 |
| 2025-10-14 |
Pinto Shelly |
SVP, Finance and CAO |
RSU 付与（制限付株式） |
140,000 |
$1.70 |
$238K |
140,000 |
| 2025-10-14 |
Shantharam Harish |
Chief Financial Officer |
RSU 付与（制限付株式） |
198,750 |
$1.70 |
$337.88K |
198,750 |
| 2025-09-17 |
Lettmann Jason |
Chief Executive Officer |
情報に基づく買い |
71,163 |
$1.08 |
$76.89K |
305,121 |
| 2025-09-17 |
Klencke Barbara |
Director |
RSU 付与（制限付株式） |
300,000 |
$1.05 |
$315K |
300,000 |
| 2025-09-16 |
Lettmann Jason |
Chief Executive Officer |
情報に基づく買い |
21,070 |
$1.07 |
$22.46K |
233,958 |
| 2025-08-18 |
Shantharam Harish |
Chief Financial Officer |
情報に基づく買い |
75,000 |
$0.78 |
$58.4K |
75,000 |
| 2025-08-15 |
Lettmann Jason |
Chief Executive Officer |
情報に基づく売り |
2,382 |
$0.64 |
$1.53K |
212,888 |
| 2025-08-15 |
Pinto Shelly |
SVP, Finance and CAO |
情報に基づく売り |
611 |
$0.64 |
$391.28 |
89,198 |
| 2025-08-12 |
Curran Daniel J. |
Officer |
不明 |
- |
- |
- |
- |
| 2025-08-12 |
Curran Daniel J. |
Director |
RSU 付与（制限付株式） |
40,400 |
$0.62 |
$24.85K |
40,400 |
| 2025-07-07 |
Pinto Shelly |
SVP, Finance and CAO |
情報に基づく売り |
2,011 |
$0.45 |
$905.15 |
86,809 |
| 2025-06-30 |
Pinto Shelly |
SVP, Finance and CAO |
情報に基づく売り |
1,532 |
$0.43 |
$658.76 |
88,820 |
| 2025-04-11 |
Lettmann Jason |
Chief Executive Officer |
RSU 付与（制限付株式） |
125,000 |
$0.49 |
$61.25K |
125,000 |
| 2025-04-11 |
Sandler Alan B. |
Chief Medical Officer |
RSU 付与（制限付株式） |
125,000 |
$0.49 |
$61.25K |
125,000 |
| 2025-04-11 |
Pinto Shelly |
SVP, Finance and CAO |
RSU 付与（制限付株式） |
90,000 |
$0.49 |
$44.1K |
90,000 |
| 2025-04-11 |
Shantharam Harish |
Chief Financial Officer |
RSU 付与（制限付株式） |
125,000 |
$0.49 |
$61.25K |
125,000 |
| 2025-03-14 |
Lettmann Jason |
Chief Executive Officer |
RSU 付与（制限付株式） |
42,000 |
- |
- |
212,270 |
| 2025-03-14 |
Pinto Shelly |
SVP, Finance and CAO |
RSU 付与（制限付株式） |
3,000 |
- |
- |
90,352 |
| 2025-02-19 |
Lettmann Jason |
Chief Executive Officer |
情報に基づく売り |
2,159 |
$1.15 |
$2.48K |
170,270 |
| 2025-02-19 |
Pons Jaume |
President & CSO |
情報に基づく売り |
1,326 |
$1.15 |
$1.53K |
579,388 |
| 2025-02-19 |
Pinto Shelly |
SVP, Finance and CAO |
情報に基づく売り |
550 |
$1.15 |
$632.61 |
87,352 |
| 2025-01-21 |
Goodman Corey S |
10 Percent Owner |
RSU 付与（制限付株式） |
40,400 |
$1.65 |
$66.66K |
40,400 |
| 2025-01-21 |
Garland J. Scott |
Director |
RSU 付与（制限付株式） |
40,400 |
$1.65 |
$66.66K |
40,400 |
| 2025-01-21 |
Klencke Barbara |
Director |
不明 |
- |
- |
- |
60,000 |
| 2025-01-21 |
Klencke Barbara |
Director |
RSU 付与（制限付株式） |
40,400 |
$1.65 |
$66.66K |
40,400 |
| 2025-01-21 |
Lettmann Jason |
Chief Executive Officer |
RSU 付与（制限付株式） |
478,000 |
$1.65 |
$788.7K |
478,000 |
| 2025-01-21 |
Takimoto Chris H |
Officer |
不明 |
- |
- |
- |
- |
| 2025-01-21 |
Takimoto Chris H |
Director |
RSU 付与（制限付株式） |
40,400 |
$1.65 |
$66.66K |
40,400 |
| 2025-01-21 |
Hemrajani Rekha |
Director |
RSU 付与（制限付株式） |
40,400 |
$1.65 |
$66.66K |
40,400 |
| 2025-01-21 |
Pons Jaume |
President & CSO |
RSU 付与（制限付株式） |
50,000 |
$1.65 |
$82.5K |
50,000 |
| 2025-01-21 |
Sandler Alan B. |
Chief Medical Officer |
RSU 付与（制限付株式） |
100,000 |
$1.65 |
$165K |
100,000 |
| 2025-01-21 |
Pinto Shelly |
SVP, Finance and CAO |
RSU 付与（制限付株式） |
112,000 |
$1.65 |
$184.8K |
112,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
